Tests for equivalence or noninferiority between two proportions

Drug Information Journal

Volumn 34, Issue 2, 2000, Pages 569-578

  Chen, James J ^a   Tsong, Yi ^b   Kang, Seung Ho ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Asymptotic test; Binomial; Bioequivalence; Conditional exact test; Difference; Odds ratio; Ratio

Indexed keywords

ARTICLE; BIOEQUIVALENCE; OUTCOMES RESEARCH; PHARMACOKINETICS; PRIORITY JOURNAL; PROBABILITY; STATISTICS;

EID: 0034114838     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150003400225     Document Type: Article

References (18)

1. Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Marcel Decker; 1992.
2. FDA. Guidance on statistical procedure for bioequivalence studies using a standard two-treatment crossover design. Rockville, MD: Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Adminis ration; 1992.
3. FDA. Guidance - Topical Dermatologic Corticosteroids: In vivo bioequivalence. Rockville, MD: Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration; 1995.
4. Schurrmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharm Biopharm. 1987;15:657-680.
5. Berger RL, Hsu JC. Bioequivalence trials, intersection-union tests and equivalence confidence sets. Stat Sci. 1996;11:283-318.
6. Rodaiy C, Com-Nougue C, Tournade M. How to establish equivalence between treatments: a one-sided clinical trial in pediatric oncology. Stat Med. 1989;8:593-598.
7. Dunnett CW, Gent M. Significance testing to establish equivalence between treatments with special reference to data in the form of 2 x 2 tables. Biometrics. 1977;33:593-602.
8. Huque MF, Dubey S. Design and analysis for therapeutic equivalence clinical trials with binary clinical endpcints. The 1990 Proceedings of the Biopharmaceutical Section of the American Statistical Association. 1990;91-98.
9. Blackwelder WC. Proving the null hypothesis in clinicil trials. Control Clin Trials. 1982;3:345-353.
10. Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med. 1990;9:1447-1454.
11. Tu D. A comparative study of some statistical procedures in establishing therapeutic equivalence of non-systemic drugs with binary endpoints. Drug Inf J. 1997;31:1291-1300.
12. Agresti A. Categorical Data Analysis. New York: John Wiley & Sons; 1990.
13. O'Neill RT. On the sample sizes to estimate the protective efficacy of vaccine. Stat Med. 1988;7: 1279-1288.
14. Thomas DG, Gart JJ. A table of exact confidence limits for differences and ratios of two proportions ad their odds ratios. J Am Stat Assoc. 1977;72:73-76.
15. Lehmann EL. Testing Statistical Hypothesis, 2nd ed. New York: Wiley; 1986.
16. Agresti A. A Survey of Exact Inference for Contingency Tables. Stat Sci. 1992;7:131-177.
17. Fisher RA. The logic of inductive inference. J Royal Stat Society, Series A. 1935;98:39-54.
18. Mehta CR, Patel NR, Tsiatis AA. Exact significance testing to establish treatment equivalence with ordered categorical data. Biometrics. 1984;40:819-825.